BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 35267131)

  • 21. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
    Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
    Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior.
    Bhat AM; Mohapatra BC; Luan H; Mushtaq I; Chakraborty S; Kumar S; Wu W; Nolan B; Dutta S; Storck MD; Schott M; Meza JL; Lele SM; Lin MF; Cook LM; Corey E; Morrissey C; Coulter DW; Rowley MJ; Natarajan A; Datta K; Band V; Band H
    Sci Rep; 2024 Jun; 14(1):13523. PubMed ID: 38866755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ceramide moiety of disialoganglioside (GD3) is essential for GD3 recognition by the sialic acid-binding lectin SIGLEC7 on the cell surface.
    Hashimoto N; Ito S; Tsuchida A; Bhuiyan RH; Okajima T; Yamamoto A; Furukawa K; Ohmi Y; Furukawa K
    J Biol Chem; 2019 Jul; 294(28):10833-10845. PubMed ID: 31138648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycolipid GD3 and GD3 synthase are key drivers for glioblastoma stem cells and tumorigenicity.
    Yeh SC; Wang PY; Lou YW; Khoo KH; Hsiao M; Hsu TL; Wong CH
    Proc Natl Acad Sci U S A; 2016 May; 113(20):5592-7. PubMed ID: 27143722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in glycosphingolipid composition during differentiation of human leukemic granulocytes in chronic myelogenous leukemia compared with in vitro granulocytic differentiation of human promyelocytic leukemia cell line HL-60.
    Nojiri H; Takaku F; Ohta M; Miura Y; Saito M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6100-6. PubMed ID: 3864527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment.
    Marijan S; Markotić A; Mastelić A; Režić-Mužinić N; Pilkington LI; Reynisson J; Čulić VČ
    Sci Rep; 2020 Jul; 10(1):11876. PubMed ID: 32680999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency.
    Brimble SN; Sherrer ES; Uhl EW; Wang E; Kelly S; Merrill AH; Robins AJ; Schulz TC
    Stem Cells; 2007 Jan; 25(1):54-62. PubMed ID: 17008424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Traveling for the glycosphingolipid path.
    Hakomori S
    Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Fluorescently Labeled SSEA-3, SSEA-4, and Globo-H Glycosphingolipids for Elucidating Molecular Interactions in the Cell Membrane.
    Asano S; Pal R; Tanaka HN; Imamura A; Ishida H; Suzuki KGN; Ando H
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells.
    Fenderson BA; Andrews PW; Nudelman E; Clausen H; Hakomori S
    Dev Biol; 1987 Jul; 122(1):21-34. PubMed ID: 3297853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).
    Sandhoff R; Sandhoff K
    Adv Neurobiol; 2023; 29():333-390. PubMed ID: 36255681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosphingolipid glycosyltransferases in human fetal brain.
    Percy AK; Gottfries J; Vilbergsson G; Månsson JE; Svennerholm L
    J Neurochem; 1991 May; 56(5):1461-5. PubMed ID: 1901591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines.
    Guan F; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7461-6. PubMed ID: 19380734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.
    Müthing J; Cacić M
    Glycoconj J; 1997 Jan; 14(1):19-28. PubMed ID: 9076510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycosphingolipid-Glycan Signatures of Acute Myeloid Leukemia Cell Lines Reflect Hematopoietic Differentiation.
    Wang D; Zhang T; Madunić K; de Waard AA; Blöchl C; Mayboroda OA; Griffioen M; Spaapen RM; Huber CG; Lageveen-Kammeijer GSM; Wuhrer M
    J Proteome Res; 2022 Apr; 21(4):1029-1040. PubMed ID: 35168327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional role of glycosphingolipids in contact inhibition of growth in a human mammary epithelial cell line.
    Huang X; Schurman N; Handa K; Hakomori S
    FEBS Lett; 2017 Jul; 591(13):1918-1928. PubMed ID: 28586101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.
    Gupta V; Bhinge KN; Hosain SB; Xiong K; Gu X; Shi R; Ho MY; Khoo KH; Li SC; Li YT; Ambudkar SV; Jazwinski SM; Liu YY
    J Biol Chem; 2012 Oct; 287(44):37195-205. PubMed ID: 22936806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Embryonic stem cells with a disrupted GD3 synthase gene undergo neuronal differentiation in the absence of b-series gangliosides.
    Kawai H; Sango K; Mullin KA; Proia RL
    J Biol Chem; 1998 Jul; 273(31):19634-8. PubMed ID: 9677390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of Glycosphingolipid Glycans and Chondrogenic Markers during Differentiation of Human Induced Pluripotent Stem Cells into Chondrocytes.
    Xu L; Hanamatsu H; Homan K; Onodera T; Miyazaki T; Furukawa JI; Hontani K; Tian Y; Baba R; Iwasaki N
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33271874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.